Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

Siddhi N Paudel; Brian J Hutzen; Katherine E Miller; Elizabeth A R Garfinkle; Chun-Yu Chen; Pin-Yi Wang; Andrea M Glaspell; Mark A Currier; Emily M Ringwalt; Louis Boon; Elaine R Mardis; Mitchell S Cairo; Nancy Ratner; Rebecca D Dodd; Kevin A Cassady; Timothy P Cripe

doi:10.3389/fimmu.2024.1456897

Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors

Front Immunol. 2024 Jul 9:15:1456897. doi: 10.3389/fimmu.2024.1456897. eCollection 2024.

Authors

Siddhi N Paudel¹, Brian J Hutzen¹, Katherine E Miller^{2

3}, Elizabeth A R Garfinkle², Chun-Yu Chen¹, Pin-Yi Wang¹, Andrea M Glaspell¹, Mark A Currier¹, Emily M Ringwalt¹, Louis Boon⁴, Elaine R Mardis^{2

3}, Mitchell S Cairo⁵, Nancy Ratner⁶, Rebecca D Dodd⁷, Kevin A Cassady^{1

3}, Timothy P Cripe^{1

3

8}

Affiliations

¹ Center for Childhood Cancer Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
² Institute for Genomic Medicine, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
³ Department of Pediatrics, The Ohio State University Wexner College of Medicine, Columbus, OH, United States.
⁴ JJP Biologics, Warsaw, Poland.
⁵ Department of Pediatrics, Medicine, Pathology, Microbiology and Immunology, and Cell Biology, New York Medical College, Valhalla, NY, United States.
⁶ Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
⁷ Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, United States.
⁸ Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1384623.].

Keywords: T-VEC; immunotherapy; macrophage targeting; malignant peripheral nerve sheath tumors; oncolytic virotherapy; pexidartinib; trabectedin; tumor microenvironment.

Publication types

Published Erratum

MeSH terms

Animals
Combined Modality Therapy
Disease Models, Animal*
Humans
Immunotherapy / methods
Mice
Oncolytic Virotherapy* / methods
Oncolytic Viruses / genetics
Oncolytic Viruses / immunology